Research Progress on the Experimental Animal Model of Gestational Diabetes Mellitus

References

• Chiefari E, Arcidiacono B, Foti D, Brunetti A. Gestational diabetes mellitus: an updated overview. J Endocrinol Invest. 2017;40(9):899–909. doi:10.1007/s40618-016-0607-5
   PubMed Web of Science ®Google Scholar
• Xin L. Research progress of experimental gestational diabetes rat model. Prog Mod Obstet Gynecol. 2012;21(8):648–650.
   Google Scholar
• Koopmans SJ, VanderMeulen J, Wijdenes J, Corbijn H, Dekker R. The existence of an insulin-stimulated glucose and non-essential but not essential amino acid substrate interaction in diabetic pigs. BMC Biochem. 2011;12:25. doi:10.1186/1471-2091-12-25
   PubMedGoogle Scholar
• Yu W, Wu N, Li L, OuYang H, Qian M, Shen HA. Review of research progress on glycemic variability and gestational diabetes. Diabetes Metab Syndr Obes. 2020;13:2729–2741. doi:10.2147/DMSO.S261486
   PubMed Web of Science ®Google Scholar
• Yuan N, Zhai H, Du D, Shan X, Wang M. Advances in pathogenesis of gestational diabetes mellitus. J Guangxi Med Univ. 2019;36(2):321–324.
   Google Scholar
• Song D, Ran L, Jiang R, Yingjie W. Progress of animal models in diabetes research. Chin J Comp Med. 2016;26(9):83–87.
   Google Scholar
• Baeyens L, Hindi S, Sorenson RL, German MS. Beta-Cell adaptation in pregnancy. Diabetes Obes Metab. 2016;18(Suppl 1):63–70. doi:10.1111/dom.12716
   PubMed Web of Science ®Google Scholar
• Moyce BL, Dolinsky VW. Maternal beta-cell adaptations in pregnancy and placental signalling: implications for gestational diabetes. Int J Mol Sci. 2018;19(11):3467. doi:10.3390/ijms19113467
   PubMed Web of Science ®Google Scholar
• Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51(2):216–226. doi:10.1007/s00125-007-0886-7
   PubMed Web of Science ®Google Scholar
• RAKIETEN N, RAKIETEN ML, NADKARNI MR. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep.1963;29:91-98
   Google Scholar
• Jiang J, Chunwei W, Xing L, et al. Establishment of gestational diabetes rat model with different doses of streptozotocin. J Guiyang Med Coll. 2010;35(3):221–223.
   Google Scholar
• Cui Y, Yang D, Zhang Q, et al. Comparative study on STZ induced type 2 and type 1 diabetic rat models. J Med Res. 2018;47(5):36–38.
   Google Scholar
• Hao Q, Song C. Establishment of gestational diabetes mellitus mouse model by two methods. World Latest Med Inf Abstr. 2019;19(6):185–186.
   Google Scholar
• Jia L, Wei B, Ta N, Chen B. Comparison of the stability of different doses of streptozotocin in the establishment of gestational diabetes mellitus rat model. J Fourth Mi Med Univ. 2009;30(22):2500–2502.
   Google Scholar
• Zhuang J, Ying H, Wang D. Study on the establishment of gestational diabetes mellitus rat model with low-dose streptozotocin. Prog Mod Obstet Gynecol. 2014;8:607–610.
   Google Scholar
• Drews G, Kramer C, Dufer M, Krippeit-Drews P. Contrasting effects of alloxan on islets and single mouse pancreatic beta-cells. Biochem J. 2000;352(Pt 2):389–397. doi:10.1042/bj3520389
   PubMedGoogle Scholar
• Gai W, Schott-Ohly P, Schulte IWS, Gleichmann H. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro. Exp Clin Endocrinol Diabetes. 2004;112(1):29–37. doi:10.1055/s-2004-815724
   PubMedGoogle Scholar
• Liang J, Yang S, Wen M, Wei S. Establishment of diabetic pregnancy rat model by alloxan. Chin Maternal Child Health Res. 2006;17(6):454–456.
   Google Scholar
• Shui Y, Xia X, Zhang Q, Zhang C, Yuanzhe W. Changes of dipeptidyl peptidase 4 activity in alloxan induced diabetic pregnant rats. Southeast Natl Defense Med. 2015;6:568–571.
   Google Scholar
• Linxia L, Wang Y, Yan Q, et al. Establishment of gestational hyperglycemia animal model by continuous intravenous infusion of hypertonic glucose. Shanghai Med. 2006;29(5):306–308.
   Google Scholar
• Zhang J. Establishment of mouse model of gestational diabetes mellitus induced by high fat and high sugar diet and Study on lipid metabolism characteristics: internal medicine. Ningxia Medical University; 2013. Available from: http://www.wanfangdata.com.cn/details/detail.do?_type=degree&id=D421746. Accessed October 09, 2020.
   Google Scholar
• Huang B, Huang C, Zhao H, et al. Impact of GPR1 signaling on maternal high-fat feeding and placenta metabolism in mice. Am J Physiol Endocrinol Metab. 2019;316(6):E987–E997. doi:10.1152/ajpendo.00437.2018
   PubMedGoogle Scholar
• Vuong B, Odero G, Rozbacher S, et al. Exposure to gestational diabetes mellitus induces neuroinflammation, derangement of hippocampal neurons, and cognitive changes in rat offspring. J Neuroinflammation. 2017;14(1):80. doi:10.1186/s12974-017-0859-9
   PubMedGoogle Scholar
• Ren J, Ding Y, Yin L, et al. Effects of high-sucrose/high-fat diet feeding time on establishment of a mouse model of gestational diabetes mellitus. J Hyg Res. 2018;47(1):128–133.
   Google Scholar
• Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab. 2003;88(8):3507–3512. doi:10.1210/jc.2003-030186
   PubMed Web of Science ®Google Scholar
• Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care. 2003;26(3):819–824. doi:10.2337/diacare.26.3.819
   PubMed Web of Science ®Google Scholar
• Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519–525. doi:10.1097/01.AOG.0000113621.53602.7a
   PubMed Web of Science ®Google Scholar
• Kautzky-Willer A, Pacini G, Tura A, et al. Increased plasma leptin in gestational diabetes. Diabetologia. 2001;44(2):164–172. doi:10.1007/s001250051595
   PubMedGoogle Scholar
• Zhou G, Cong L. Research progress on the relationship between adiponectin and pregnancy. Foreign Med. 2007;34(3):159–161.
   Google Scholar
• Chen L, Huang X, Yang Y, et al. Establishment of gestational diabetes mellitus mouse model induced by high fat diet combined with STZ. Chin J Comp Med. 2016;26(3):15–18.
   Google Scholar
• Tang M, Wenting X, Wang C, Wang L. Optimization of high fat diet combined with streptozotocin in induced gestational diabetes rat model. J Jiangsu Univ. 2018;28(5):393–396.
   Google Scholar
• Yang R, Qingwang L, Zhao R. Comparison of the effects of alloxan and streptozotocin on diabetic mice. J Northwest Agric Forest Univ. 2006;34(2):17–20.
   Google Scholar
• Abdul AS, John CM, Mohamed YN, et al. Animal model of gestational diabetes mellitus with pathophysiological resemblance to the human condition induced by multiple factors (Nutritional, pharmacological, and stress) in rats. Biomed Res Int. 2016;2016:9704607.
   PubMedGoogle Scholar
• Kaufmann RC, Amankwah KS, Dunaway G, Maroun L, Arbuthnot J, Roddick JJ. An animal model of gestational diabetes. Am J Obstet Gynecol. 1981;141(5):479–482. doi:10.1016/S0002-9378(15)33263-4
   PubMedGoogle Scholar
• Yamashita H, Shao J, Qiao L, Pagliassotti M, Friedman JE. Effect of spontaneous gestational diabetes on fetal and postnatal hepatic insulin resistance in Lepr(db/+) mice. Pediatr Res. 2003;53(3):411–418. doi:10.1203/01.PDR.0000049667.58071.7D
   PubMed Web of Science ®Google Scholar
• Yamashita H, Shao J, Ishizuka T, et al. Leptin administration prevents spontaneous gestational diabetes in heterozygous Lepr(db/+) mice: effects on placental leptin and fetal growth. Endocrinology. 2001;142(7):2888–2897. doi:10.1210/endo.142.7.8227
   PubMedGoogle Scholar
• Holemans K, Caluwaerts S, Poston L, Van Assche FA. Diet-induced obesity in the rat: a model for gestational diabetes mellitus. Am J Obstet Gynecol. 2004;190(3):858–865. doi:10.1016/j.ajog.2003.09.025
   PubMed Web of Science ®Google Scholar
• Fujinaka Y, Takane K, Yamashita H, Vasavada RC. Lactogens promote beta cell survival through JAK2/STAT5 activation and Bcl-XL upregulation. J Biol Chem. 2007;282(42):30707–30717. doi:10.1074/jbc.M702607200
   PubMedGoogle Scholar
• Banerjee RR, Cyphert HA, Walker EM, et al. Gestational diabetes mellitus from inactivation of prolactin receptor and MafB in Islet beta-Cells. Diabetes. 2016;65(8):2331–2341. doi:10.2337/db15-1527
   PubMedGoogle Scholar
• Arumugam R, Fleenor D, Freemark M. Knockdown of prolactin receptors in a pancreatic beta cell line: effects on DNA synthesis, apoptosis, and gene expression. Endocrine. 2014;46(3):568–576. doi:10.1007/s12020-013-0073-1
   PubMedGoogle Scholar
• Nteeba J, Kubota K, Wang W, et al. Pancreatic prolactin receptor signaling regulates maternal glucose homeostasis. J Endocrinol. 2019;241(1):71–83. doi:10.1530/JOE-18-0518
   Google Scholar
• Demirci C, Ernst S, Alvarez-Perez JC, et al. Loss of HGF/c-Met signaling in pancreatic beta-cells leads to incomplete maternal beta-cell adaptation and gestational diabetes mellitus. Diabetes. 2012;61(5):1143–1152.
   PubMedGoogle Scholar
• Kim H, Toyofuku Y, Lynn FC, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16(7):804–808. doi:10.1038/nm.2173
   PubMed Web of Science ®Google Scholar
• Martin-Montalvo A, Lopez-Noriega L, Jimenez-Moreno C, et al. Transient PAX8 expression in Islets during pregnancy correlates with beta-cell survival, revealing a novel candidate gene in gestational diabetes mellitus. Diabetes. 2019;68(1):109–118. doi:10.2337/db18-0285
   PubMed Web of Science ®Google Scholar
• Pasek RC, Gannon M. Advancements and challenges in generating accurate animal models of gestational diabetes mellitus. Am J Physiol Endocrinol Metab. 2013;305(11):E1327–E1338. doi:10.1152/ajpendo.00425.2013
   PubMedGoogle Scholar
• Moore MC, Menon R, Coate KC, et al. Diet-induced impaired glucose tolerance and gestational diabetes in the dog. J Appl Physiol. 2011;110(2):458–467. doi:10.1152/japplphysiol.00768.2010
   PubMedGoogle Scholar
• Ford SP, Zhang L, Zhu M, et al. Maternal obesity accelerates fetal pancreatic β-cell but not α-cell development in sheep: prenatal consequences. Am J Physiol Regul Integr Comp Physiol. 2009;297(3):R835–R843. doi:10.1152/ajpregu.00072.2009
   PubMed Web of Science ®Google Scholar
• Dickinson JE, Meyer BA, Chmielowiec S, Palmer SM. Streptozocin-induced diabetes mellitus in the pregnant ewe. Am J Obstet Gynecol. 1991;165(6 Pt 1):1673–1677. doi:10.1016/0002-9378(91)90013-H
   PubMedGoogle Scholar
• Miodovnik M, Mimouni F, Berk M, Clark KE. Alloxan-induced diabetes mellitus in the pregnant ewe: metabolic and cardiovascular effects on the mother and her fetus. Am J Obstet Gynecol. 1989;160(5 Pt 1):1239–1244. doi:10.1016/0002-9378(89)90203-2
   PubMedGoogle Scholar
• Lips JP, Jongsma HW, Eskes TK. Alloxan-induced diabetes mellitus in pregnant sheep and chronic fetal catheterization. Lab Anim. 1988;22(1):16–22. doi:10.1258/002367788780746638
   PubMedGoogle Scholar
• Ramsay TG, Wolverton CK, Steele NC. Alteration in IGF-I mRNA content of fetal swine tissues in response to maternal diabetes. Am J Physiol. 1994;267(5 Pt 2):R1391–R1396.
   PubMedGoogle Scholar
• Ezekwe MO, Ezekwe EI, Sen DK, Ogolla F. Effects of maternal streptozotocin-diabetes on fetal growth, energy reserves and body composition of newborn pigs. J Anim Sci. 1984;59(4):974–980. doi:10.2527/jas1984.594974x
   PubMedGoogle Scholar
• Ryan EA, Tobin BW, Tang J, Finegood DT. A new model for the study of mild diabetes during pregnancy. Syngeneic islet-transplanted STZ-induced diabetic rats. Diabetes. 1993;42(2):316–323. doi:10.2337/diab.42.2.316
   PubMedGoogle Scholar
• Damasceno DC, Netto AO, Iessi IL, et al. Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes. Biomed Res Int. 2014;2014:819065. doi:10.1155/2014/819065
   PubMedGoogle Scholar
• American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes–2020. Diabetes Care. 2020;43(Suppl1):S14–s31. doi:10.2337/dc20-S002
   Google Scholar
• ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol. 2018;131(2):e49–e64.
   Google Scholar
• Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131 Suppl 3:S173–S211.
   PubMedGoogle Scholar
• Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–682.
   Google Scholar
• Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341–363.
   Google Scholar
• Society. CD. Guidelines for the prevention and control of type 2 diabetes in China (2017 Edition). Chin J Pract Intern Med. 2018;38 (4):292–344.
   Google Scholar
• endocrinology Cso. Experts consensus on management of glycemic variability of diabetes mellitus. Drug Evaluation. 2017;014(17):5–8,14.
   Google Scholar